Postoperative Noncirrhotic Hyperammonemia Secondary to Disseminated Ureaplasma parvum in a Nontransplant Adult Patient: A Case Report
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Ureaplasma species are urease‐producing organisms that can cause fulminant hyperammonemia with rapid neurologic deterioration. Ureaplasma ‐associated hyperammonemia has been most often described in solid organ transplant recipients, with only rare reports in nontransplant patients receiving chronic immunosuppressive therapy. We present the case of a 45‐year‐old woman with multiple sclerosis and seronegative arthritis treated with immunomodulatory agents who developed culture‐negative septic shock and severe hyperammonemia after gastric surgery. Despite broad‐spectrum antimicrobials, measures to limit protein intake and catabolism, renal replacement therapy, and aggressive intracranial pressure‐directed management, serum ammonia peaked above 600 μ mol·L −1 (reference range: 11–60 μ mol·L −1 ), resulting in refractory cerebral edema and death on postoperative day 14. Ureaplasma parvum was ultimately identified by polymerase chain reaction testing of urine and abdominal fluid. This case highlights the need to consider Ureaplasma infection in nontransplant patients receiving immunosuppressive therapy who develop altered mental status and hyperammonemia, particularly when routine cultures are negative. Early molecular testing, targeted antimicrobial therapy, and aggressive ammonia‐ and intracranial pressure–lowering interventions may be lifesaving.
Fields of Study & Subjects
Microbial infections and disease research
Infections and bacterial resistance
Sepsis Diagnosis and Treatment
Publication details
- Journal / source
- Case Reports in Critical Care
- Volume
- 2026
- Issue
- 1
- Pages
- 7521571
- Publication date
- 1 January 2026
- Language
- EN